Codes / ICD10CM / T38.992

T38.992 Poisoning by other hormone antagonists, intentional self-harm

ICD10CM code

ICD10CM

Name of the Condition

  • Poisoning by other hormone antagonists, intentional self-harm

Summary

This condition describes intentional self-harm resulting from exposure to hormone antagonists not classified elsewhere. It covers deliberate ingestion or exposure to these substances, which may lead to adverse effects or toxic reactions. The code applies when the specific agent is identified but not categorized under more precise codes.

Causes

The causes involve intentional exposure to hormone antagonists, which may occur through deliberate ingestion, handling, or self-administration. These agents can disrupt normal hormonal function, leading to harmful physiological responses when exposure is intentional. Intentional exposure may stem from suicidal ideation or self-harm behaviors.

Risk Factors

  • History of mental health conditions (e.g., depression, anxiety)
  • Prior self-harm or suicidal attempts
  • Access to hormone antagonist medications
  • Substance use disorders
  • Social or environmental stressors

Symptoms

Symptoms depend on the specific hormone antagonist involved and may include metabolic disturbances, endocrine imbalances, or organ-specific effects. Common manifestations could include altered hormone levels, organ dysfunction, or systemic reactions.

Diagnosis

Diagnosis requires a thorough patient history to identify intentional exposure, along with clinical evaluation of symptoms and laboratory tests to assess hormonal and organ function. Toxicology screening may help identify the specific agent involved.

Treatment Options

Treatment focuses on stabilizing the patient, managing symptoms, and addressing the underlying self-harm behavior. This may include supportive care, antidotes (if available), and psychiatric evaluation. Long-term management may involve mental health support and safety planning.

Prognosis and Follow-Up

Prognosis depends on the severity of poisoning, timely intervention, and the patient’s response to treatment. Follow-up care should include ongoing psychiatric support and monitoring for recurrence of self-harm behaviors.

Complications

Complications may include organ damage, metabolic imbalances, or long-term endocrine dysfunction. Severe cases can lead to life-threatening conditions requiring intensive care.

Lifestyle & Prevention

Prevention involves securing medications, providing mental health resources, and educating patients on safe storage and disposal of hormonal agents. Supportive environments and access to crisis intervention can reduce risk.

When to Seek Professional Help

Seek immediate medical attention if intentional exposure to hormone antagonists is suspected, or if symptoms such as severe metabolic disturbances, organ failure, or altered mental status occur.

Tips for Medical Coders

Document the specific hormone antagonist involved, the intent (intentional self-harm), and any associated clinical details. Ensure the code aligns with the clinical scenario and documentation of self-harm behavior.